Filed: 2/2/2023ACC: 0000950123-23-000672
📋 What this filing means
OUP MANAGEMENT CO., LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $61.25M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$61.25M
Total AUM (reported)
12.66M
Total Shares
Allocation by class
COMMON STOCK$52.15M85.1%
SPONSORED ADS$9.11M14.9%
Portfolio Concentration
Top 3$35.40M57.8%
4–10$23.92M39.1%
11–25$1.92M3.1%
Top 3 weight
57.8%
Top 10 weight
96.9%
Voting Authority Distribution
Total shares with voting rights: 12.66M
Sole
Full voting authority
12.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
Aerovate Therapeutics Inc.
SOLEShares603.76K
TypeSH
Market value$17.69M
28.88%
Sole
603.76K
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares2.94M
TypeSH
Market value$9.11M
14.87%
Sole
2.94M
Shared
0.00
None
0.00
PMV Pharmaceuticals, Inc.
SOLEShares989.23K
TypeSH
Market value$8.61M
14.05%
Sole
989.23K
Shared
0.00
None
0.00
DICE Therapeutics Inc.
SOLEShares268.35K
TypeSH
Market value$8.37M
13.67%
Sole
268.35K
Shared
0.00
None
0.00
ionQ, Inc.
SOLEShares1.18M
TypeSH
Market value$4.06M
6.63%
Sole
1.18M
Shared
0.00
None
0.00
Cyteir Therapeutics, Inc.
SOLEShares2.46M
TypeSH
Market value$4.06M
6.63%
Sole
2.46M
Shared
0.00
None
0.00
Vor Biopharma Inc.
SOLEShares374.71K
TypeSH
Market value$2.49M
4.07%
Sole
374.71K
Shared
0.00
None
0.00
Prime Medicine, Inc.
SOLEShares121.25K
TypeSH
Market value$2.25M
3.68%
Sole
121.25K
Shared
0.00
None
0.00
Graphite Bio
SOLEShares406.31K
TypeSH
Market value$1.35M
2.20%
Sole
406.31K
Shared
0.00
None
0.00
Precision BioSciences, Inc.
SOLEShares1.12M
TypeSH
Market value$1.34M
2.18%
Sole
1.12M
Shared
0.00
None
0.00
Selecta Biosciences, Inc.
SOLEShares862.54K
TypeSH
Market value$974.7K
1.59%
Sole
862.54K
Shared
0.00
None
0.00
eFFECTOR Therapeutics, Inc.
SOLEShares1.03M
TypeSH
Market value$438.6K
0.72%
Sole
1.03M
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares249.07K
TypeSH
Market value$430.9K
0.70%
Sole
249.07K
Shared
0.00
None
0.00
Homology Medicines, Inc.
SOLEShares64K
TypeSH
Market value$80.6K
0.13%
Sole
64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Aerovate Therapeutics Inc.SOLE | Common Stock | 603.76K | SH | $17.69M 28.88% | 603.76K | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | Sponsored ADS | 2.94M | SH | $9.11M 14.87% | 2.94M | 0.00 | 0.00 |
PMV Pharmaceuticals, Inc.SOLE | Common Stock | 989.23K | SH | $8.61M 14.05% | 989.23K | 0.00 | 0.00 |
DICE Therapeutics Inc.SOLE | Common Stock | 268.35K | SH | $8.37M 13.67% | 268.35K | 0.00 | 0.00 |
ionQ, Inc.SOLE | Common Stock | 1.18M | SH | $4.06M 6.63% | 1.18M | 0.00 | 0.00 |
Cyteir Therapeutics, Inc.SOLE | Common Stock | 2.46M | SH | $4.06M 6.63% | 2.46M | 0.00 | 0.00 |
Vor Biopharma Inc.SOLE | Common Stock | 374.71K | SH | $2.49M 4.07% | 374.71K | 0.00 | 0.00 |
Prime Medicine, Inc.SOLE | Common Stock | 121.25K | SH | $2.25M 3.68% | 121.25K | 0.00 | 0.00 |
Graphite BioSOLE | Common Stock | 406.31K | SH | $1.35M 2.20% | 406.31K | 0.00 | 0.00 |
Precision BioSciences, Inc.SOLE | Common Stock | 1.12M | SH | $1.34M 2.18% | 1.12M | 0.00 | 0.00 |
Selecta Biosciences, Inc.SOLE | Common Stock | 862.54K | SH | $974.7K 1.59% | 862.54K | 0.00 | 0.00 |
eFFECTOR Therapeutics, Inc.SOLE | Common Stock | 1.03M | SH | $438.6K 0.72% | 1.03M | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 249.07K | SH | $430.9K 0.70% | 249.07K | 0.00 | 0.00 |
Homology Medicines, Inc.SOLE | Common Stock | 64K | SH | $80.6K 0.13% | 64K | 0.00 | 0.00 |